Expertise and excellence for preclinical
drug delivery businesses

Fibrofind identifies pathways and anti-fibrotic targets and advises the most optimal research solutions to test your anti-fibrotic compound.

  • Kidney Fibrosis

  • Chronic Liver Diseases

  • Lung Fibrosis

The First Annual Meeting of Fibrofind LTD will be held on Friday 6th, December 2019
Location to be confirmed soon only on request at contact@fibrofind.com